Viewing Study NCT00376961


Ignite Creation Date: 2025-12-24 @ 12:56 PM
Ignite Modification Date: 2026-05-17 @ 5:33 AM
Study NCT ID: NCT00376961
Status: COMPLETED
Last Update Posted: 2017-11-06
First Post: 2006-09-13
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: SWOG Cancer Research Network
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None contiguous stage II mantle cell lymphoma View
None noncontiguous stage II mantle cell lymphoma View
None stage III mantle cell lymphoma View
None stage IV mantle cell lymphoma View